Cambridge Investment Research Advisors
QTTB icon

Cambridge Investment Research Advisors’s Q32 Bio QTTB Stock Holding History

Cambridge Investment Research Advisors’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$230K Sell
18,081
-16,944
-48% -$142K ﹤0.01% 3697
2026
Q1 		$225K Buy
+35,025
New +$166K ﹤0.01% 3576

Other funds holding QTTB

S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
AF
Advisornet Financial Minnetonka, Minnesota $2.19B AUM 21.28% 1-Year Est. Return
KFP
Kerr Financial Planning Fresno, California $89.6M AUM 72.71% 1-Year Est. Return

Cambridge Investment Research Advisors's QTTB Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Q32 Bio (QTTB) stake by 48% in Q2 2026, selling an estimated $142K and leaving 18,081 shares worth $230K. The position accounts for ﹤0.01% of the portfolio, ranked #3697.

Cambridge Investment Research Advisors first reported a position in QTTB in Q1 2026 and has held it in 2 quarters since. 6 funds tracked by Wall St. Rank hold QTTB as of Q2 2026.

  • Cambridge Investment Research Advisors held 18,081 shares of Q32 Bio worth $230K as of Q2 2026.
  • Cambridge Investment Research Advisors sold 16,944 Q32 Bio shares in Q2 2026, an estimated $142K.
  • Q32 Bio made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3697 holding.
  • Cambridge Investment Research Advisors first reported a position in Q32 Bio in Q1 2026 and has held it in 2 quarters since.
  • 6 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.